Pre-implementation Study to Develop Trans-tailored Services for Transgender Persons in Relation to chemsEX
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: Understanding of chemsex patterns, impacts, and service needs among transgender persons.
- Who it may be relevant to
- Registry conditions: Substance Use, HIV Prevention, Sexually Transmitted Infections (STIs). Basic parameters: from 18 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- Thailand
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Overview
The study is a pre-implementation cross-sectional study exploring chemsex behaviors among transgender persons and gathering perspectives from multiple stakeholders to inform the development of transgender-tailored harm reduction services.
Detailed description
This study is designed under the EPIS framework (Exploration and Preparation phases) to better understand chemsex use among transgender populations in Thailand.
The study aims to:
* Explore reasons and patterns of chemsex use * Assess positive and negative impacts (physical, sexual, mental, and socio-legal) * Identify key components, barriers, and facilitators for developing transgender-tailored chemsex services
Data will be collected using a mixed-methods approach, including:
* In-depth interviews (IDIs) * Self-administered questionnaires Participants include transgender chemsex users, their family/partners, and stakeholders such as healthcare providers and policymakers.
Interventions
- Behavioral Understanding of chemsex patterns, impacts, and service needs among transgender persons
: During study period (single visit within \~12 months study duration)
Primary outcome measures
- Key themes on chemsex behaviors and service needs [Time frame: At interview (single time point)]
- Barriers and facilitators to implementation of transgender-tailored chemsex services [Time frame: At interview (single time point)]
- Chemsex-related behavioral and demographic characteristics [Time frame: At interview (single time point)]
- HIV-related stigma score [Time frame: Baseline, Month 3, Month 6]
- Transgender-related stigma score [Time frame: Baseline, Month 3, Month 6]
- PrEP adherence (self-reported adherence score) [Time frame: Baseline, Month 3, Month 6]
- Intervention acceptability score [Time frame: Month 3]
Eligibility criteria
Inclusion criteria
- Age ≥18 years
- Able to communicate in Thai
- Provide informed consent
Exclusion criteria
- Unable to participate in in-depth interview (IDI) (online or onsite)
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: Yes
Study design
- Observational model
- Other
Study locations
Thailand · 1 center
- Tangerine Clinic, Institute of HIV Research and Innovation — Pathum Wan
Identifiers
NCT: NCT07505875 · IHRI028